ABSI is trading at $6.46 (up 6.2%), extending its week-long rally as the stock continues to see upward momentum despite a lack of fresh company-specific news.
- The advance follows a sharp 17.8% gain on May 28, 2026, as the stock tracks a broadly positive equity market.
- No new earnings, M&A activity, FDA updates, or major analyst calls have been reported to account for today's price action.